You may find more results for this query on our sister sites: GenomeWeb and Precision Oncology News.
NEW YORK ─ The US Food and Drug Administration on Tuesday revoked its Emergency Use Authorization of Chembio Diagnostic's DPP COVID-19 IgM/IgG test because of concerns about its sensitivity and specificity.
...and receive Daily News bulletins.
Already have a 360Dx or GenomeWeb account?Login Now.
Don't have a 360Dx or GenomeWeb account?Register for Free.